vs
Liberty Latin America Ltd.(LILA)とRevvity(RVTY)の財務データ比較。上の社名をクリックして会社を切り替えられます
Liberty Latin America Ltd.の直近四半期売上が大きい($1.2B vs $772.1M、Revvityの約1.5倍)。Revvityの純利益率が高く(12.7% vs -4.7%、差は17.5%)。Revvityの前年同期比売上増加率が高い(5.9% vs 1.7%)。Liberty Latin America Ltd.の直近四半期フリーキャッシュフローが多い($320.1M vs $161.8M)。過去8四半期でRevvityの売上複合成長率が高い(9.0% vs 2.7%)
リバティ・ラテンアメリカ・リミテッドは多国籍通信事業者で、2005年にリバティ・メディアの国際部門とUnitedGlobalCom(UGC)の合併により設立されました。登記地はバミューダ、ロンドン、アムステルダム、デンバーに本拠地を置き、英国・オランダなど複数の地域で事業主体を展開し、通信サービスを提供しています。
レブィティ(Revvity, Inc.)は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
LILA vs RVTY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $1.2B | $772.1M |
| 純利益 | $-54.8M | $98.4M |
| 粗利率 | 77.3% | — |
| 営業利益率 | 10.8% | 14.5% |
| 純利益率 | -4.7% | 12.7% |
| 売上前年比 | 1.7% | 5.9% |
| 純利益前年比 | 74.0% | 3.9% |
| EPS(希薄化後) | $-0.27 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.2B | $772.1M | ||
| Q3 25 | $1.1B | $698.9M | ||
| Q2 25 | $1.1B | $720.3M | ||
| Q1 25 | $1.1B | $664.8M | ||
| Q4 24 | $1.1B | $729.4M | ||
| Q3 24 | $1.1B | $684.0M | ||
| Q2 24 | $1.1B | $691.7M | ||
| Q1 24 | $1.1B | $649.9M |
| Q4 25 | $-54.8M | $98.4M | ||
| Q3 25 | $3.3M | $46.7M | ||
| Q2 25 | $-423.3M | $53.9M | ||
| Q1 25 | $-136.4M | $42.2M | ||
| Q4 24 | $-210.4M | $94.6M | ||
| Q3 24 | $-435.8M | $94.4M | ||
| Q2 24 | $-42.7M | $55.4M | ||
| Q1 24 | $-500.0K | $26.0M |
| Q4 25 | 77.3% | — | ||
| Q3 25 | 77.7% | 53.6% | ||
| Q2 25 | 78.6% | 54.5% | ||
| Q1 25 | 78.5% | 56.5% | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 78.7% | 56.3% | ||
| Q2 24 | 78.1% | 55.7% | ||
| Q1 24 | 78.2% | 54.6% |
| Q4 25 | 10.8% | 14.5% | ||
| Q3 25 | 16.9% | 11.7% | ||
| Q2 25 | -30.6% | 12.6% | ||
| Q1 25 | 11.8% | 10.9% | ||
| Q4 24 | 8.7% | 16.3% | ||
| Q3 24 | -34.9% | 14.3% | ||
| Q2 24 | 9.9% | 12.4% | ||
| Q1 24 | 8.4% | 6.8% |
| Q4 25 | -4.7% | 12.7% | ||
| Q3 25 | 0.3% | 6.7% | ||
| Q2 25 | -39.0% | 7.5% | ||
| Q1 25 | -12.6% | 6.4% | ||
| Q4 24 | -18.5% | 13.0% | ||
| Q3 24 | -40.0% | 13.8% | ||
| Q2 24 | -3.8% | 8.0% | ||
| Q1 24 | -0.0% | 4.0% |
| Q4 25 | $-0.27 | $0.86 | ||
| Q3 25 | $0.02 | $0.40 | ||
| Q2 25 | $-2.12 | $0.46 | ||
| Q1 25 | $-0.69 | $0.35 | ||
| Q4 24 | $-1.03 | $0.77 | ||
| Q3 24 | $-2.22 | $0.77 | ||
| Q2 24 | $-0.22 | $0.45 | ||
| Q1 24 | $0.00 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $783.9M | $919.9M |
| 総負債低いほど良い | $7.9B | — |
| 株主資本純資産 | $555.6M | $7.3B |
| 総資産 | $12.2B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | 14.17× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $783.9M | $919.9M | ||
| Q3 25 | $596.7M | $931.4M | ||
| Q2 25 | $514.4M | $991.8M | ||
| Q1 25 | $575.5M | $1.1B | ||
| Q4 24 | $654.3M | $1.2B | ||
| Q3 24 | $588.6M | $1.2B | ||
| Q2 24 | $598.6M | $2.0B | ||
| Q1 24 | $668.5M | $1.7B |
| Q4 25 | $7.9B | — | ||
| Q3 25 | $7.8B | — | ||
| Q2 25 | $7.6B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.6B | — | ||
| Q2 24 | $7.6B | — | ||
| Q1 24 | $7.6B | — |
| Q4 25 | $555.6M | $7.3B | ||
| Q3 25 | $628.9M | $7.4B | ||
| Q2 25 | $608.4M | $7.6B | ||
| Q1 25 | $1.0B | $7.6B | ||
| Q4 24 | $1.1B | $7.7B | ||
| Q3 24 | $1.2B | $7.9B | ||
| Q2 24 | $1.7B | $7.9B | ||
| Q1 24 | $1.7B | $7.8B |
| Q4 25 | $12.2B | $12.2B | ||
| Q3 25 | $12.0B | $12.1B | ||
| Q2 25 | $12.0B | $12.4B | ||
| Q1 25 | $12.6B | $12.4B | ||
| Q4 24 | $12.8B | $12.4B | ||
| Q3 24 | $12.7B | $12.8B | ||
| Q2 24 | $13.2B | $13.4B | ||
| Q1 24 | $13.3B | $13.4B |
| Q4 25 | 14.17× | — | ||
| Q3 25 | 12.45× | — | ||
| Q2 25 | 12.50× | — | ||
| Q1 25 | 7.47× | — | ||
| Q4 24 | 6.99× | — | ||
| Q3 24 | 6.20× | — | ||
| Q2 24 | 4.59× | — | ||
| Q1 24 | 4.38× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $461.9M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $320.1M | $161.8M |
| FCFマージンFCF / 売上 | 27.6% | 21.0% |
| 設備投資強度設備投資 / 売上 | 12.2% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | — | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $305.9M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $461.9M | $182.0M | ||
| Q3 25 | $178.2M | $138.5M | ||
| Q2 25 | $141.2M | $134.3M | ||
| Q1 25 | $24.6M | $128.2M | ||
| Q4 24 | $398.6M | $174.2M | ||
| Q3 24 | $177.5M | $147.9M | ||
| Q2 24 | $156.9M | $158.6M | ||
| Q1 24 | $23.3M | $147.6M |
| Q4 25 | $320.1M | $161.8M | ||
| Q3 25 | $56.0M | $120.0M | ||
| Q2 25 | $1.9M | $115.5M | ||
| Q1 25 | $-72.1M | $112.2M | ||
| Q4 24 | $234.9M | $149.8M | ||
| Q3 24 | $51.0M | $125.6M | ||
| Q2 24 | $16.4M | $136.6M | ||
| Q1 24 | $-86.4M | $129.7M |
| Q4 25 | 27.6% | 21.0% | ||
| Q3 25 | 5.0% | 17.2% | ||
| Q2 25 | 0.2% | 16.0% | ||
| Q1 25 | -6.7% | 16.9% | ||
| Q4 24 | 20.6% | 20.5% | ||
| Q3 24 | 4.7% | 18.4% | ||
| Q2 24 | 1.5% | 19.7% | ||
| Q1 24 | -7.9% | 20.0% |
| Q4 25 | 12.2% | 2.6% | ||
| Q3 25 | 11.0% | 2.6% | ||
| Q2 25 | 12.8% | 2.6% | ||
| Q1 25 | 8.9% | 2.4% | ||
| Q4 24 | 14.4% | 3.4% | ||
| Q3 24 | 11.6% | 3.3% | ||
| Q2 24 | 12.6% | 3.2% | ||
| Q1 24 | 10.0% | 2.7% |
| Q4 25 | — | 1.85× | ||
| Q3 25 | 54.00× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
LILA
| Liberty Cablevisionof Puerto Rico LLC Liberty Puerto Rico | $301.3M | 26% |
| Cable Wireless Communications Limited CW Panama | $230.1M | 20% |
| Costa Rica Segment | $168.2M | 15% |
| Liberty Networks | $129.3M | 11% |
| Cable Subscription | $112.4M | 10% |
| Mobile Subscription | $95.9M | 8% |
| Mobile Handset And Other Devices | $73.0M | 6% |
| Liberty Networks Other | $25.0M | 2% |
| Mobile Non Subscription | $21.6M | 2% |
| B2B Mobile Handsetand Other Devices | $7.0M | 1% |
| Cable Non Subscription | $4.3M | 0% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |